Skip to main content
Clinical Trials/CTRI/2014/11/005227
CTRI/2014/11/005227Not yet recruiting未知

Prospective observational study of thromboembolic events in patients of advanced stage Non small cell lung cancer(NSCLC) treated with platinum based chemotherapy.

Tata Memorial Hospital0 sites167 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Enrollment
167

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • INCLUSION CRITERIA:
  • Lung cancer patients (age >18 years) who are started on platinum based chemotherapy.

Exclusion Criteria

  • EXCLUSION CRITERIA:
  • 1. Age <18 years
  • 2. Patients in whom therapy is discontinued prior to completion of 6 weeks due to any reason.
  • 3. Presence of any thromboembolic event before start of chemotherapy including deep venous thrombosis (DVT), pulmonary embolus, cerebrovascular accident, and unstable angina/myocardial infarction (MI).
  • 4.Patients with bleeding diathesis, inherited coagulopathy, and those requiring therapeutic anticoagulation, regular nonsteroidal anti-inflammatory drugs, and aspirin.
  • 5. Patients receiving angiogenesis inhibitor drug- bevacizumab.

Investigators

Similar Trials